Buy B Green Innovations

In: Tips

18 Dec 2014

Hi Everybody,

Last week was spectacular, with our alerts showing price gains of 150% and 90%. We heard from many of you that were able to put some nice profits in the bank.

For those of you that are still looking to put some holiday cash in your pocket, our alert for Wednesday looks like it is oversold and ready for a bounce.

A few months ago this stock bounced from this area and made almost a 300% price gain so traders will be getting ready to load up expecting another big move from here.

Our alert for Thursday is:
B Green Innovations, Inc.
Ticker symbol: BGNN
Last price: $0.11

BGNN creates useful consumer products from recycled materials.

BGNN sells its products to wholesale distributors in the heating and air conditioning, motors, plumbing, maintenance, electrical, tools, and refrigeration industries, as well as to supermarket chains and other retail sales outlets.

BGNN has quite a few products in their portfolio:

• EcoPod, a shock absorption pad that is used to reduce sound, vibrations, and pulsating of heavy equipment.

• VibeAway anti-vibration pads that are specially designed for washing machines.

• Wrap-N-Save, a plastic film for sealing paint trays, paint brushes and rollers.

• The Sock Pocket Organizer, holds paired socks in place through washing machine and dryer cycles…no more stranded single socks!

• The Ice Pack Sack, a simple, comfortable, and effective method for applying hot and cold therapy. It provides relief from sprains, strains and common muscle pain.

The timing could be perfect.

Get ready to book your profits with BGNN!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy Digipath

In: Tips

11 Dec 2014

Hi Everybody,

Monday’s alert hit a high of .016 for a price gain of 150% over 2 days. Congratulations to everyone who got in on that one.

We hope you’re ready for another big winner!

Our next alert looks awesome, as a matter of fact, this may be the biggest no brainer trade ever.

Why?

Because this company has $5 million cash in the bank and a market cap of $2.4 million. That is like buying a $100 bill for 50 bucks.

When the market notices this company is undervalued to cash, the price will adjust higher and you could put some serious cash in your pockets.

Let’s get to the details.

Our alert for Thursday is:
Digipath, Inc.
Ticker symbol: DIGP
Last price: $0.029

DIGP, is an independent cannabis consulting firm. The market for cannabis grew to $1.3 billion in 2013 with projections to reach over $10 billion by 2018.

DIGP finished its fiscal year with $5.1 million in cash, contributing to assets totaling $5.7 million with total liabilities of less than $200K.

Developments are adding up:

• DIGP raised an impressive $8.2 million from accredited investors during its third fiscal quarter 2014.

• DIGP allocated $1 million of gross proceeds to general working capital for its digital pathology unit.

• DIGP invested another $1 million in content and curriculum development for the company’s forthcoming cannabis education and training unit.

The projected growth DIGP is obviously attributable to the increased legalization of cannabis across the US, as more and more states continue to bring to the forefront new legalization efforts.

In turn, this will create an explosive need for quality testing labs, education, and unbiased news!

According to industry experts, legal cannabis is on track to post 60% growth this year, raking in over $2.5 billion in revenue.

Everyone always talks about being at the right place at the right time.

DIGP is in a hot industry and Thursday morning looks like the right time.

Get ready to book your profits with DIGP!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Hi Everybody,

Cancer kills 7.6 million people a year. Fortunes are spent by companies conducting research and development of treatments in an effort to eliminate this horrible disease.

Our alert for Monday is one of them and now may be the right time for smart traders looking to make some money to jump on it.

Why?
1. It’s price is below a penny so every uptick in price means big profits.
2. It’s a biotech company and the market loves these companies because their prices can explode overnight.
3. This company is getting ready to move it’s cancer fighting products from the research phase to the FDA clinical trial phase and that’s when these stocks really heat up.

Our alert for Monday is:
Propanc Health Group Corp.
Ticker symbol: PPCH
Last price: $0.0065

PPCH is a biotech company focused on the development of new cancer treatments.

PPCH has spent the last 15 years in developing two products for patients with advanced stages of solid tumor cancers such as lung, colorectal, ovarian cancer, pancreatic cancer and liver cancers.

PPCH hopes that encouraging early results will be replicated in large, controlled clinical trials required for regulatory approval.

Now, we’re not scientists or a doctors but one thing we do know is how to make money in the stock market, and the potential of their treatment is the kind of stuff that gets the sub penny crowd fired up.

With exposure coming PPCH’s way we could see a serious influx of activity in the stock, providing that volatility we need for huge winning trades.

Get ready to book your profits with PPCH!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy Lans Holdings

In: Tips

4 Dec 2014

Hi Everybody,

If you are ready for a high profit potential play then get ready for Thursday’s alert!

Our alert for Thursday is:
Lans Holdings, Inc.
Ticker symbol: LAHO
Last price: $0.22

LAHO is in the online payment business, you know, the stuff that made Paypal a $30 billion company.

LAHO isn’t Paypal, but down here at $0.22 even a whisper of the Paypal buzz has finally got the stock moving.

LAHO makes the payment processing, sales initiation, and humble beginnings of a website easy. It is a win-win situation for both sides, and they take on clients of all shapes, sizes and ages. They make it easy for sellers to start selling, and buyers to buy with confidence.

Running e-commerce sites is what turns start-up companies like Square into $6 billion venture capital darlings, so LAHO is in a space investors are lining up to participate in.

Square makes maybe $110 million revenue a year and they’re worth $6 billion.

LAHO is a lot more modest, writing in $5 million as a goal in their transition papers, but then the company is also only valued at $23 million right now.

Do the math and LAHO looks like one serious growth opportunity.

Investors have already shown excitement, as LAHO closed up 45% on Wednesday, and could get even more exciting as the stock continues to receive more awareness.

Get ready to book your profits with LAHO!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Hi Everybody,

We have a trade for Wednesday, a company that may have some exciting news in the pipeline, looking to grab a foothold in a 50 billion dollar industry.

Our alert for Wednesday is:
Hollund Industrial Marine, Inc.
Ticker symbol: HIMR
Last price: $0.04

HIMR is an integrated underwater natural resource project management company focused on underwater forestry.

What is underwater forestry? Exactly what it sounds like, harvesting trees from underwater. Before you scoff, consider that there are over 300 million trees standing underwater. This a growing industry that’s worth more than $50 billion annually!

So why is HIMR well positioned in this industry?

HIMR has access to the patented Tiger-Lynk Technology. Tiger-Lynk is an industrial-grade harvester designed specifically for harvesting standing timber in shallow reservoirs (up to 120 feet deep).

After several months of planning HIMR was finally cleared to begin harvesting on Panama’s Bayano Reservoir.

The government issued permit HIMR received also allows them to farm Tilapia (cichlid fish) in the reservoir, something they can do after they have cleared the timber. This news means HIMR will be making money coming and going…literally.

The news of HIMR’s permit to harvest came back at the end of June, so we could expect to see some progress soon.

With HIMR beginning to receive exposure, we could see an exciting move starting tomorrow.

Get ready to book your profits with HIMR.

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy MIT Holding

In: Tips

20 Nov 2014

Hi Everybody,

We’re excited to bring you what could be a really fun trade.

It’s an interesting penny play that has recently recorded its first net profit in 6 years! With 3Q numbers expected to hit any day, this might be the ideal time to look at this stock.

Our alert for Thursday is:
MIT Holding, Inc.
Ticker symbol: MITD
Last price: $0.10

MITD is in the healthcare industry and has some awesome things going on that make it a very interesting trade opportunity to look at.

MITD has been a revenue producing company for years, but right now is an extremely exciting time for the company.

MITD has recorded a net profit of approximately 21K at the end of Q2 2014. This is a major milestone as it is the first quarterly profit for the company in six years!

This is a net turnaround of 360K from the same quarter in 2013.

Why are we bringing this to you now?

MITD’s 3rd quarter numbers could be hitting any day, and judging by the increases seen in the first 6 months, we might see some good numbers, which could make for huge profits for anyone involved before the announcement.

But that’s not all!

MITD just announced a new revenue stream with up to 52% gross profits. MITD is the sub investigator in a Phase 3 clinical trial for Melinta Therapeutics.

The study will be conducted over 12 months with six hundred and sixty patients.

MITD CEO Walter Drakeford, said of the study, “Our test the waters approach to a new revenue stream with these types of margins, are being proven effective with this study. The facilities and employees have met or exceeded all investigative expectations associated with this lucrative and specialized field. This approach has allowed us to streamline our process and provide proof of our capabilities as we look to expand this contract to its maximum commitment, beginning immediately.”

Make sure you’re ready to book profits with MITD!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy Dalton Industries

In: Tips

19 Nov 2014

Hi Everybody,

There is a whole new world of entertainment just around the corner and investors stand to score big by placing early bets on the sector.

What are we talking about? Virtual Reality.

Virtual Reality (VR), is a computer-simulated environment that simulates you actually being a part of a story instead of just watching it like TV or video games. It is the next level of engagement.

How do we know this is going to be big? Well, Facebook shelled out 2 billion dollars to acquire the manufacturer of Oculus VR one of the early leaders in the industry and Sony & Google have also announced big projects in this space.

Our alert for Wednesday is:
Dalton Industries, Inc.
Ticker symbol: DALT
Last price: 5 cents

Dalton Industries Inc. produces digital content with a heavy focus on virtual reality.

Companies that produce high quality content and applications for this industry are going to get rich and that’s why you need to take a serious look at DALT.

DALT is lead by president Kelly Lee Myers who is an award-winning film/TV visual effects veteran with more than 20 years experience.

The rest of the DALT staff have loads of credits to their names too.

DALT has acquired the the production, distribution, and merchandising rights to Amadhia Albee’s Kaze: Ghostwarrior (a samurai fantasy show) and STASYS (a sci-fi program)

Both Kaze and STASYS sound like stories that could become wildly popular in this format.

DALT also plans on releasing a series of digital action figures and virtual playSets to accompany these shows.

The cost of these kits will range from $20 to $50 dollars and more kits will be added as the show’s plot lines progress.

DALT’s ubercam 2.0, which is still in beta is pretty cool too.

It allows programmers to design and develop their VR media directly in the Oculus Rift, rather than having to continuously export files from their workspace to game engines just to see what the finished product will look and feel like. Allowing designers to bring VR media to market that much quicker.

DALT gives investors a chance to get in on the impending VR boom. Wednesday morning could be a big day as DALT is receiving major awareness.

Make sure you’re ready to book profits with DALT!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy Ecosciences

In: Tips

17 Nov 2014

Hi Everybody,

We love it when we find a company with a clever solution to a big problem because those companies can make investors serious money.

We found one for Monday morning that does just that.

Our alert for Monday is:
Ecosciences, Inc.
Ticker symbol: ECEZ
Last price: 25 cents

ECEZ produces a suite of soluble tablets that that break down organic waste like sludge, including fats, oils and grease without the need of expensive equipment or hazardous chemicals.

ECEZ’s tablets can be used to clean waste water in restaurants, wastewater facilities, lift stations, pump stations, grease traps, septic sewer systems, car wash systems, portable toilets, ponds & lakes, and farms.

Let’s take restaurants for example, they usually have 25-100 gallon grease traps they need to clean

The current solution for cleaning them is mechanical pumping. This can be time consuming, sometimes dangerous and quite expensive. Costs range between $4,000 and $8000 a year to pump depending on the city.

ECEZ’s solution costs $400 annually!

If you owned a restaurant, would you rather pay 4 to 8 thousand to deal with waste maintenance or 400?

ECEZ could be a game changer in the food service industry, but that’s just one of many applications for ECEZ’s tablets. If they can get a foothold across all the industries their tablets could be the solution for the revenues could get pretty impressive.

This company is just starting to receive awareness today and could start to heat up as investors learn the potential this company has.

Make sure you’re ready to book profits with ECEZ!

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy Aim Exploration

In: Tips

11 Nov 2014

Hi Everybody,

Our alert for Tuesday is a junior mining company that produces feldspar, which is is used to manufacture glass products, ceramics, paint, in mild abrasives, urethane, latex foam, as welding rod coatings, other end products and anthracite coal which is used in the manufacturing of steel, cement, and the generation of electricity.

Our alert for Tuesday is:
Aim Exploration, Inc.
Ticker symbol: AEXE
Last price: $0.47

AEXE is a junior mining company with a current focus on feldspar in the Philippines and anthracite coal in Peru.

AEXE is about to go from the exploration and development phase to the production phase and that is typically a very exciting time for a junior mining company.

Take a look at the numbers that caught our attention. We think the market is going to find them very exciting as well.

Here’s the projections from their anthracite coal project in Peru:

• First 18 months of operations;
o AEXE expects to produce coal for $51 dollars a ton and sell domestically for $80. That is a 38% profit margin.

• 19 months going forward;
o Production costs are expected to drop to $34 as additional mining operations come on line which increase margins to 60%.

Typical coal companies operate at closer to 20% margins so all of a sudden these numbers become pretty attractive.

In addition to the coal operations, their feldspar project is now in production as well and we expect to see some strong numbers.

AEXE is now planning to expand the production facility to accommodate production for large-scale glass manufacturers as well as traditional ceramic manufacturers which is expected to be completed by the first half of 2015.

Now feldspar and anthracite coal may not be the most exciting minerals but if AEXE starts putting up numbers like they project, this stock is going to heat up in a hurry. Make sure you take a look and get ready to book your profits with AEXE.

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading

Buy Sunshine Biopharma

In: Tips

3 Nov 2014

Hi Everybody,

According to the American Cancer Society approximately 1.5 million new cases of cancer are diagnosed each year in the U.S. Today, there are over 11 million Americans living with cancer.

Our alert for Monday is in the development process of a patented anti-cancer compound.

Our alert for Monday is:
Sunshine Biopharma, Inc.
Ticker symbol: SBFM
Last price: 10 cents

SBFM is a pharmaceutical company that researches, develops and commercialises drugs for the treatment of various forms of cancer,

Adva-27a is SBFM’s patented lead anticancer compound, a small molecule that has recently been shown to be effective at killing multidrug resistant breast cancer cells, small-cell lung cancer cells, uterine sarcoma cells and pancreatic cancer cells.

The early stage preclinical studies for SBFM’s lead compound, Adva-27a, were successfully completed.

SBFM is planning a phase 1 clinical trial of Adva-27a for pancreatic cancer in parallel to the phase 1 clinical trial of Adva-27a for multidrug resistant breast cancer.

Recently, SBFM has been making the necessary steps to get to trials.

SBFM is currently negotiating with several contract research organizations (CRO’s) with the intent to engage one of them for the purposes of initiating, compiling and managing a regulatory master drug file for Adva-27a. A master drug file contains all of the information that regulatory agencies require as part of the drug development and approval process.

SBFM is also preparing to sell generic pharmaceuticals in an effort to produce revenues that should help fund the costly process associated with clinical trials.

SBFM has secured dedicated space in order to commence operations in the generic pharmaceuticals business as planned. Having a specifically dedicated space is required in order for the company to be granted a Pharmaceutical Establishment and Export License by Health Canada.

Once secured the establishment license will allow SBFM to sign manufacturing and distribution contracts for sale of generic pharmaceuticals in Canada and elsewhere around the globe.

As SBFM gets closer to clinical trials the stock could really heat up.

If you aren’t familiar with the clinical trial process, each stage when successfully completed is usually the catalyst for a large move for the stock.

SBFM is receiving a ton of awareness this week and we think traders and investors alike will benefit from buyers coming in ahead of phase 1.

Get ready to book your profits with SBFM.

Free Stock TipsAs always, do your own research, don’t chase gaps, use limit orders to enter positions, always use stop loss orders to protect your position, and take profits when you are in a position to do so.

Good Trading


Categories

Thanks to our sponsors